Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2021
Source ID
10.1016/j.annonc.2021.06.003

Entities

People

  • A.a. Hamid
  • C.j. Sweeney
  • D.e. Spratt
  • E. Davicioni
  • E.m. Van Allen
  • Fan Feng
  • G. Attard
  • G. Liu
  • H.-c. Huang
  • M.a. Carducci
  • P.t. Tran
  • R. Den
  • R. Dipaola
  • R. Dittamore
  • V. Wang
  • Y.-h. Chen

Organizations

  • National Cancer Institute
  • National Health and Medical Research Council
  • National Institutes of Health
  • Prostate Cancer Foundation
  • Sanofi-Aventis
  • United States Department of Defense